Jan Adams is a partner at Apollo focusing on company creation, one of the cornerstones of Apollo’s investment strategy. His career spans venture investing, company building, strategy consulting and basic research in the life sciences. Jan previously headed commercial activities at the Merck KGaA Innovation Center and was a managing director with EMBL Ventures, a seed and early-stage VC that was working closely with the EMBL, Europe’s flagship laboratory in the life sciences.
Jan is a trained biochemist with a master’s from Tübingen University and a PhD in molecular genetics from the University of Cambridge, UK as well as a dual MBA degree from ESSEC (Paris) and Mannheim University with distinction.
Jan is a Class 11 Kauffman Fellow and a recipient of each, a Boehringer Ingelheim PhD, and an Ernst-Schering Post-doctoral Research Fellowship.